We’re thrilled to share that Biotts has been selected as one of the finalists for the Investor Pitch at the RESI Europe London Edition on December 4, 2024.

Thank you to everyone who joined us at SAE’s 3rd Annual Transdermal and Microneedle Drug Delivery Conference in London on November 11-12.

We are excited to announce that Biotts will be attending SAE’s 3rd Annual Transdermal and Microneedle Drug Delivery Conference in London, UK, on November 11-12, 2024!

The 2024 PODD Conference in Boston brought together leaders and innovators from across the pharmaceutical, biotech, and drug delivery sectors. We were honored to participate and showcase Biotts’ latest advancements in transdermal drug delivery.

Join Biotts at PODD 2024 conference to witness the transformative potential of MTC-Y transdermal technology. Our innovative platform has demonstrated exceptional capabilities in insulin delivery, paving the way for new possibilities in drug delivery.

We are excited to announce that Biotts will be attending CPHI Milan from October 8th to 10th at Fiera Milano, Italy.